MOSAIC update confirms FOLFOX4 disease-free survival advantage: Commentary Journal Article

  

Author:	Lichtman, S. M.
Article Title:	MOSAIC update confirms FOLFOX4 disease-free survival advantage: Commentary
Keywords:	cancer survival; treatment response; overall survival; clinical trial; neutropenia; bevacizumab; fluorouracil; cancer combination chemotherapy; treatment duration; adjuvant therapy; cancer adjuvant therapy; disease free survival; cancer staging; neurotoxicity; colorectal cancer; metastasis; multiple cycle treatment; sensory neuropathy; cetuximab; high risk patient; risk assessment; survival time; statistical significance; folinic acid; cancer relapse; short survey; colorectal surgery; hazard ratio; oxaliplatin; risk reduction
Journal Title:	The Oncology Report
Issue:	Fall
ISSN:	1548-5323
Publisher:	International Medical News Group LLC
Date Published:	2007-09-01
Start Page:	36
Language:	English
PROVIDER:	scopus
DOI/URL:	http://www.scopus.com/inward/record.url?eid=2-s2.0-40449139574&partnerID=40&md5=6e944af330a431fd18f8bca6c54e029f
Notes:	--- - "Export Date: 17 November 2011" - "Source: Scopus"

https://synapse.mskcc.org/synapse/works/has_related_data_chk/17730